Biocon Ltd
SEC insider (Form 3/4/5 filer). CIK 0002036170. 10% Owner at Bicara Therapeutics Inc. (BCAX). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2024. Located in BANGALORE, K7.
Companies Biocon Ltd has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): 10% Owner
Biocon Ltd
CIK: 0002036170
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCAX
Bicara Therapeutics Inc.
10% Owner